[Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology].

Values were determined by means of a ligand binding assay using 17-FE (17-fluoresceinated estrone) in 53 breast cancer patients. 49.1% of the tumors were positive and 50.